Highlands Oncology Group — Fayetteville, Arkansas

Highlands Oncology Group is a clinical research site located in Fayetteville, Arkansas, United States 72703.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Highlands Oncology Group has participated in 112 clinical trials with 17 currently active.

Therapeutic areas: Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma.

Sponsors: CTI BioPharma, Novartis Pharmaceuticals, Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Highlands Oncology Group?

Highlands Oncology Group has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Highlands Oncology Group conducted?

Highlands Oncology Group has 112 clinical trials on record, with 17 currently active. Their work covers Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma.

Is Highlands Oncology Group accredited by Crixeo Health?

Highlands Oncology Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Highlands Oncology Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.